These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


305 related items for PubMed ID: 34495816

  • 1. In-vitro activity of fosfomycin against Escherichia coli and Klebsiella pneumoniae bloodstream isolates and frequency of OXA-48, NDM, KPC, VIM, IMP types of carbapenemases in the carbapenem-resistant groups.
    Zarakolu P, Eser ÖK, Otlu B, Gürpınar Ö, Özakın C, Akalın H, Köksal İ, Ünal S.
    J Chemother; 2022 Jul; 34(4):235-240. PubMed ID: 34495816
    [Abstract] [Full Text] [Related]

  • 2. [Investigation of carbapenemases in carbapenem-resistant Escherichia coli and Klebsiella pneumoniae strains isolated in 2014 in Turkey].
    Çakar A, Akyön Y, Gür D, Karatuna O, Öğünç D, Özhak Baysan B, Çöplü N, Çağatay M, Kılıç A, Baysallar M, Bakıcı Z, Çelik C, Gülay Z, Aydemir Ş, Tünger A, Kılıç H, Erçal BD, Aşçı Toraman Z, Zer Y, Büyüktaş A, Ay S, Aktaş Z, Kayacan Ç, Bayramoğlu G, Aydın F, Dündar D, Hasdemir U, Ayaş R, Yanık K, Günaydın M, Güdücüoğlu H, Parlak M.
    Mikrobiyol Bul; 2016 Jan; 50(1):21-33. PubMed ID: 27058326
    [Abstract] [Full Text] [Related]

  • 3. Multicentre investigation of carbapenemase-producing Klebsiella pneumoniae and Escherichia coli in Bulgarian hospitals - Interregional spread of ST11 NDM-1-producing K. pneumoniae.
    Markovska R, Stoeva T, Boyanova L, Stankova P, Schneider I, Keuleyan E, Mihova K, Murdjeva M, Sredkova M, Lesseva M, Nedelcheva G, Petrova A, Ivanova D, Lazarova G, Kaneva R, Mitov I.
    Infect Genet Evol; 2019 Apr; 69():61-67. PubMed ID: 30654179
    [Abstract] [Full Text] [Related]

  • 4. [Comparison of the modified Hodge test and the Carba NP test for detection of carbapenemases in Enterobacteriaceae isolates].
    Bayramoğlu G, Uluçam G, Gençoğlu Özgür Ç, Kılıç AO, Aydın F.
    Mikrobiyol Bul; 2016 Jan; 50(1):1-10. PubMed ID: 27058324
    [Abstract] [Full Text] [Related]

  • 5. Carbapenem resistance in Escherichia coli and Klebsiella pneumoniae among Indian and international patients in North India.
    Jaggi N, Chatterjee N, Singh V, Giri SK, Dwivedi P, Panwar R, Sharma AP.
    Acta Microbiol Immunol Hung; 2019 Sep 01; 66(3):367-376. PubMed ID: 31438725
    [Abstract] [Full Text] [Related]

  • 6. [The Epidemiology of Carbapenemases in Escherichia coli and Klebsiella pneumoniae Isolated in 2019 in Turkey].
    Süzük Yıldız S, Şimşek H, Bakkaloğlu Z, Numanoğlu Çevik Y, Hekimoğlu CH, Kılıç S, Alp Meşe E, Ulusal Karbapenemaz Sürveyans Çalışma Grubu.
    Mikrobiyol Bul; 2021 Jan 01; 55(1):1-16. PubMed ID: 33590977
    [Abstract] [Full Text] [Related]

  • 7. Underlying mechanisms of carbapenem resistance in extended-spectrum β-lactamase-producing Klebsiella pneumoniae and Escherichia coli isolates at a tertiary care centre in Lebanon: role of OXA-48 and NDM-1 carbapenemases.
    Baroud M, Dandache I, Araj GF, Wakim R, Kanj S, Kanafani Z, Khairallah M, Sabra A, Shehab M, Dbaibo G, Matar GM.
    Int J Antimicrob Agents; 2013 Jan 01; 41(1):75-9. PubMed ID: 23142087
    [Abstract] [Full Text] [Related]

  • 8. Multicentre investigation of carbapenemase-producing Escherichia coli and Klebsiella pneumoniae in German hospitals.
    Kaase M, Schimanski S, Schiller R, Beyreiß B, Thürmer A, Steinmann J, Kempf VA, Hess C, Sobottka I, Fenner I, Ziesing S, Burckhardt I, von Müller L, Hamprecht A, Tammer I, Wantia N, Becker K, Holzmann T, Furitsch M, Volmer G, Gatermann SG.
    Int J Med Microbiol; 2016 Sep 01; 306(6):415-20. PubMed ID: 27237423
    [Abstract] [Full Text] [Related]

  • 9. Evaluating NG-Test CARBA 5 Multiplex Immunochromatographic and Cepheid Xpert CARBA-R Assays among Carbapenem-Resistant Enterobacterales Isolates Associated with Bloodstream Infection.
    Huang YT, Kuo YW, Lee NY, Tien N, Liao CH, Teng LJ, Ko WC, Hsueh PR, SMART study group.
    Microbiol Spectr; 2022 Feb 23; 10(1):e0172821. PubMed ID: 35019772
    [Abstract] [Full Text] [Related]

  • 10. Carbapenem-resistant hypermucoviscous Klebsiella pneumoniae clinical isolates from a tertiary hospital in China: Antimicrobial susceptibility, resistance phenotype, epidemiological characteristics, microbial virulence, and risk factors.
    Wang Q, Chen M, Ou Q, Zheng L, Chen X, Mao G, Fang J, Jin D, Tang X.
    Front Cell Infect Microbiol; 2022 Feb 23; 12():1083009. PubMed ID: 36619764
    [Abstract] [Full Text] [Related]

  • 11. Characterization of Carbapenem-Resistant Enterobacteriaceae Clinical Isolates in Al Thawra University Hospital, Sana'a, Yemen.
    Alsharapy SA, Gharout-Sait A, Muggeo A, Guillard T, Cholley P, Brasme L, Bertrand X, Moghram GS, Touati A, De Champs C.
    Microb Drug Resist; 2020 Mar 23; 26(3):211-217. PubMed ID: 31397629
    [Abstract] [Full Text] [Related]

  • 12. Molecular characterization of carbapenemase producing Klebsiella pneumoniae strains by multiplex PCR and PFGE methods: The first K.pneumoniae isolates co-producing OXA-48/KPC and KPC/NDM in Turkey.
    Genç S, Kolaylı F, Özçelik EY.
    J Infect Chemother; 2022 Feb 23; 28(2):192-198. PubMed ID: 34711509
    [Abstract] [Full Text] [Related]

  • 13. Diversity of Carbapenemase-Producing Escherichia coli Isolates in France in 2012-2013.
    Gauthier L, Dortet L, Cotellon G, Creton E, Cuzon G, Ponties V, Bonnin RA, Naas T.
    Antimicrob Agents Chemother; 2018 Aug 23; 62(8):. PubMed ID: 29866863
    [Abstract] [Full Text] [Related]

  • 14. Dissemination of Carbapenemases (KPC, NDM, OXA-48, IMP, and VIM) Among Carbapenem-Resistant Enterobacteriaceae Isolated From Adult and Children Patients in China.
    Han R, Shi Q, Wu S, Yin D, Peng M, Dong D, Zheng Y, Guo Y, Zhang R, Hu F, China Antimicrobial Surveillance Network (CHINET) Study Group.
    Front Cell Infect Microbiol; 2020 Aug 23; 10():314. PubMed ID: 32719751
    [Abstract] [Full Text] [Related]

  • 15. Emergence of mcr-1 gene and carbapenemase-encoding genes among colistin-resistant Klebsiella pneumoniae clinical isolates in Jordan.
    Gharaibeh MH, Alyafawi DA, Elnasser ZA, Lafi SQ, Obeidat HM.
    J Infect Public Health; 2022 Aug 23; 15(8):922-929. PubMed ID: 35878515
    [Abstract] [Full Text] [Related]

  • 16. In vitro susceptibility of OXA-48, NDM, VIM and IMP enzyme- producing Klebsiella spp. and Escherichia coli to fosfomycin.
    Demirci-Duarte S, Unalan-Altintop T, Gulay Z, Sari Kaygisiz AN, Cakar A, Gur D.
    J Infect Dev Ctries; 2020 Apr 30; 14(4):394-397. PubMed ID: 32379717
    [Abstract] [Full Text] [Related]

  • 17. High prevalence of metallo-β-lactamase among carbapenem-resistant Klebsiella pneumoniae in a teaching hospital in China.
    Li B, Xu XH, Zhao ZC, Wang MH, Cao YP.
    Can J Microbiol; 2014 Oct 30; 60(10):691-5. PubMed ID: 25285938
    [Abstract] [Full Text] [Related]

  • 18. In vitro activity of imipenem-relebactam alone and in combination with fosfomycin against carbapenem-resistant gram-negative pathogens.
    Xu C, Chen T, Zhang S, Zhou C, Liao W, Fang R, Chen L, Zhou T.
    Diagn Microbiol Infect Dis; 2022 Jul 30; 103(3):115712. PubMed ID: 35613493
    [Abstract] [Full Text] [Related]

  • 19. Characterization of carbapenem-resistant Escherichia coli and Klebsiella pneumoniae from a healthcare region in Hong Kong.
    Ho PL, Cheung YY, Wang Y, Lo WU, Lai EL, Chow KH, Cheng VC.
    Eur J Clin Microbiol Infect Dis; 2016 Mar 30; 35(3):379-85. PubMed ID: 26740321
    [Abstract] [Full Text] [Related]

  • 20. Rapid Identification of OXA-48-like, KPC, NDM, and VIM Carbapenemase-Producing Enterobacteriaceae From Culture: Evaluation of the RESIST-4 O.K.N.V. Multiplex Lateral Flow Assay.
    Song W, Park MJ, Jeong S, Shin DH, Kim JS, Kim HS, Kim HS, Lee N, Hong JS, Jeong SH.
    Ann Lab Med; 2020 May 30; 40(3):259-263. PubMed ID: 31858767
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 16.